Organon & Co.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 9, 2026 (14 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 29, 2026 | BNP Paribas | downgrade | Outperform → Neutral | — | 51% |
| Apr 28, 2026 | Piper Sandler | upgrade | Underweight → Neutral | — | 54% |
| Feb 24, 2026 | Barclays | maintain | Underweight → Underweight | $8 | 53% |
| Dec 9, 2025 | Barclays | initiate | — → Underweight | $7.5 | 53% |
| Nov 11, 2025 | JP Morgan | maintain | Underweight → Underweight | $12 | 54% |
| Nov 11, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $9 | 54% |
| May 15, 2025 | Piper Sandler | maintain | Overweight → Overweight | $18 | 54% |
| May 5, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $10 | 54% |
| Apr 9, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $15 | 54% |
| Feb 14, 2025 | Barclays | maintain | Overweight → Overweight | $24 | 53% |
| Feb 14, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $16 | 54% |
| Sep 6, 2024 | JP Morgan | downgrade | Neutral → Underweight | $20 | 54% |
| May 6, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $20 | 54% |
| May 3, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $20 | 54% |
| Apr 29, 2024 | Piper Sandler | maintain | Overweight → Overweight | $24 | 54% |
| Feb 20, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $18 | 54% |
| Nov 22, 2023 | Piper Sandler | maintain | Overweight → Overweight | $22 | 54% |
| Nov 3, 2023 | Goldman Sachs | downgrade | Buy → Neutral | $16 | 54% |
| Oct 25, 2023 | Piper Sandler | maintain | Overweight → Overweight | $32 | 54% |
| Oct 11, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $22 | 54% |
| Sep 21, 2023 | Barclays | initiate | — → Overweight | $28 | 53% |
| Aug 9, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $27 | 54% |
| May 8, 2023 | Morgan Stanley | maintain | — → Equal-Weight | $25 | 54% |
| Mar 16, 2023 | Raymond James | initiate | — → Outperform | $33 | 54% |
| Nov 4, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $24 | 54% |
| Oct 14, 2022 | B of A Securities | downgrade | Neutral → Underperform | $25 | 53% |
| Oct 12, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $27 | 54% |
| Sep 6, 2022 | Piper Sandler | upgrade | Neutral → Overweight | $34 | 54% |
| Aug 5, 2022 | B of A Securities | downgrade | Buy → Neutral | $37 | 53% |
| Jul 8, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $34 | 54% |
| Apr 27, 2022 | Goldman Sachs | initiate | — → Buy | $40 | 54% |
| Apr 6, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $35 | 54% |
| Feb 22, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $37 | 54% |
| Oct 7, 2021 | Piper Sandler | initiate | — → Neutral | $35 | 54% |
| Sep 1, 2021 | B of A Securities | initiate | — → Buy | $43 | 53% |
| Aug 16, 2021 | Morgan Stanley | maintain | — → Equal-Weight | $35 | 54% |
| Jul 23, 2021 | Citigroup | initiate | — → Buy | $35 | 54% |
| Jul 22, 2021 | Citigroup | initiate | — → Buy | $35 | 54% |
| Jun 15, 2021 | JP Morgan | initiate | — → Neutral | $38 | 54% |
| Jun 11, 2021 | Morgan Stanley | initiate | — → Equal-Weight | $33 | 54% |
No cross-platform signals in the last 90 days